You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

~ Buy the JUXTAPID (lomitapide mesylate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR JUXTAPID


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for JUXTAPID

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01915771 ↗ Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects Completed Aegerion Pharmaceuticals, Inc. Phase 1 2013-07-29 Objectives: To evaluate the intra-subject variability of the pharmacokinetics (PK) of single oral capsule doses of 20 mg lomitapide.
NCT02044419 ↗ A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled Completed Aegerion Pharmaceuticals, Inc. Phase 1 2013-10-30 To compare the relative bioavailability of lomitapide when administered by sprinkling the contents of a 20 mg capsule of lomitapide in applesauce or in mashed banana to a single oral intact capsule dose of 20 mg lomitapide in healthy subjects.
NCT02080455 ↗ Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects. Completed Aegerion Pharmaceuticals, Inc. Phase 1 2014-01-27 The primary objective of this study is to assess the effect of atorvastatin, a weak cytochrome P450 (CYP) 3A4 inhibitor, on the pharmacokinetics (PK) of lomitapide and its 2 primary metabolites, M1 and M3.
NCT02080468 ↗ Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects Completed Aegerion Pharmaceuticals, Inc. Phase 1 2014-02-19 The primary objective of this study is to assess the effect of ethinyl estradiol (EE)/norgestimate, a weak cytochrome P450 (CYP) 3A4 inhibitor, on the pharmacokinetics (PK) of lomitapide and 2 primary metabolites, M1 and M3.
NCT02135705 ↗ LOWER: Lomitapide Observational Worldwide Evaluation Registry Recruiting Aegerion Pharmaceuticals, Inc. 2014-03-18 This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for JUXTAPID

Condition Name

Condition Name for JUXTAPID
Intervention Trials
Healthy 2
Effect of Atorvastatin on the Pharmacokinetics of Lomitapide 1
Homozygous Familial Hypercholesterolemia 1
Intra-subject Variability of Pharmacokinetics 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for JUXTAPID
Intervention Trials
Hyperlipoproteinemia Type II 1
Hypercholesterolemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for JUXTAPID

Trials by Country

Trials by Country for JUXTAPID
Location Trials
United States 28
United Kingdom 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for JUXTAPID
Location Trials
Texas 3
Pennsylvania 1
Kentucky 1
Louisiana 1
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for JUXTAPID

Clinical Trial Phase

Clinical Trial Phase for JUXTAPID
Clinical Trial Phase Trials
Phase 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for JUXTAPID
Clinical Trial Phase Trials
Completed 4
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for JUXTAPID

Sponsor Name

Sponsor Name for JUXTAPID
Sponsor Trials
Aegerion Pharmaceuticals, Inc. 5
Amryt Pharma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for JUXTAPID
Sponsor Trials
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.